Am J Physiol 1998, 274:G1061–1067 PubMed 14 Khuri FR, Wu H, Lee

Am J Physiol 1998, 274:G1061–1067.PubMed 14. Khuri FR, Wu H, Lee JJ, Kemp BL, Lotan R, Lippman SM: Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer. Clinical Cancer Research 2001, 7:861–867.PubMed 15. Xu Z, Choudhary S, Voznesensky O, Mehrotra M, Veliparib molecular weight Woodard M, Hansen M: Overexpression of COX-2 in human osteosarcoma cells decreases proliferation and increases apoptosis. Cancer Res 2006, 66:6657–6664.Ro 61-8048 cost PubMedCrossRef 16. Klein RD, Van Pelt CS, Sabichi AL, Dela Cerda J, Fischer SM, Furstenberger G: Transitional cell hyperplasia and carcinomas in urinary bladders of transgenic mice with keratin 5 promoter-driven cyclooxygenase-2

overexpression. Cancer Res 2005, 65:1808–1813.PubMedCrossRef 17. Thun MJ, Henley SJ, Patrono C: Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, CX-5461 cost pharmacologic, and clinical issues. J Natl Cancer Inst 2002, 94:252–266.PubMed 18. Fosslien E: Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia. Crit Rev Clin Lab Sci 2000, 37:431–502.PubMedCrossRef 19. Wang R, Wang X, Lin F, Gao P, Dong K, Zhang HZ: shRNA-targeted cyclooxygenase (COX)-2 inhibits proliferation, reduces invasion and enhances chemosensitivity in laryngeal carcinoma cells. Mol Cell Biochem 2008, 317:179–188.PubMedCrossRef 20. Fujita H,

Koshida K, Keller ET, Takahashi Y, Yoshimito T, Namiki M: Cyclooxygenase-2

promotes prostate cancer progression. Prostate 2002, 53:232–240.PubMedCrossRef 21. Klimp AH, Hollema H, Kempinga C, van der Zee AG, de Vries EG, Daemen T: Expression PRKD3 of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages. Cancer Res 2001, 61:7305–7309.PubMed 22. Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S: Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res 1998, 58:3761–3764.PubMed 23. Hwang D, Scollard D, Byrne J, Levine E: Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 1998, 90:455–460.PubMedCrossRef 24. Attiga FA, Fernandez PM, Weeraratna AT, Manyak MJ, Patierno SR: Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases. Cancer Res 2000, 4629–4637. 2000/09/02 ed 25. Tsujii M, DuBois RN: Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 1995, 83:493–501.PubMedCrossRef 26. Fujita T, Matsui M, Takaku K, Uetake H, Ichikawa W, Taketo MM: Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas. Cancer Res 1998, 58:4823–4826.PubMed 27.

Comments are closed.